Aug 20, 2011 by Xconomy .comSeattle Genetics Wins FDA Approval of First DrugThe agency gives a quick turnaround on the new treatment for lymphomas.
Aug 18, 2011 by Xconomy .comAre Free Motorola Phones in Our Future? A VC's Take on Why Google Is Buying MotorolaHow will this affect the mobile space?
Aug 16, 2011 by Xconomy .comQualcomm's Snaptracs -- Not SnapTrack -- Offers New Pet Tracking Technology to ConsumersQualcomm is keeping pets safe.
Aug 8, 2011 by Xconomy .comDendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry VirusIs Dendreon doomed?
Aug 6, 2011 by Xconomy .comAn Open Letter to Dendreon's ChairmanA plea to get the company back on track.
Jul 22, 2011 by Xconomy .comBristol-Myers Acquires Amira Pharmaceuticals, Scoops Up Lung DrugBMY looks to fulfill the need for a lung drug.
Jul 20, 2011 by Xconomy .comFrom Domino's to Compuware, Michigan Sees Its Future in Mobile TechnologyWant a pizza? There's an app for that.
Jul 14, 2011 by Xconomy .comSeattle Genetics Wins Unanimous OK for Lymphoma Drug from FDA PanelThe company is very excited about the drug's prospects.
Jul 12, 2011 by Xconomy .comSeattle Genetics’ New ‘Empowered Antibody’ Looks Clean in FDA Staff DocumentsFDA reviews Seattle Genetics' Hodgkin's lymphoma drug.
Jul 12, 2011 by Xconomy .comNorthrop Grumman Leads $15M Round for Daylight SolutionsThe funding will go toward new laser technology research.
Jul 8, 2011 by Xconomy .comAmylin, Alkermes Once-Weekly Diabetes Drug Passes Heart TrialWhat does this mean for the drug companies?
Jul 5, 2011 by Xconomy .comSeattle Genetics, on the Verge of Going Commercial, Seeks to Keep Its Scientific SoulExpectations are sky-high.
Jul 1, 2011 by Xconomy .comMobile Apps Are Not Just for Smartphones; Ford Courts App DevelopersWhen you think about it, Ford's foray into mobile apps makes sense for both the car maker and app makers.
Jul 1, 2011 by Xconomy .comDendreon Sways Medicare to Pay for Prostate Cancer DrugThe decision by Medicare is no surprise, but it does conclude a period of uncertainty about insurance reimbursement for its lone marketed product.
Jun 30, 2011 by Xconomy .comIBM Is Looking to Buy -- Is EMC in Its Crosshairs?Is EMC too big for IBM to swallow?
Jun 28, 2011 by Xconomy .comLost in Translation: Ford Teams With Nuance Communications to Master Human LanguageFord can't force people to adjust their speech to use its commands. Instead, Ford wants to figure out how to interpret natural human speech.
Jun 20, 2011 by Xconomy .comPfizer's Idea to Fix the Drug Development Crisis, Which Probably Won't Work (But Just Might)In a worst-case scenario, Pfizer flushes a few hundred million dollars down the tubes. What's the best-case scenario?
Jun 11, 2011 by Xconomy .comReports Say Google Wants to Buy AdmeldThe deal could go for $400 million.
Jun 6, 2011 by Xconomy .comExelixis Zeroes In on Lead Drug, Sees Activity in the Bones of Prostate Cancer PatientsIs Exelixis' risky bet about to pay off?
